P. Munozcanoves et al., INHIBITION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) ABROGATES MYOGENESIS IN-VITRO, Thrombosis and haemostasis, 77(3), 1997, pp. 526-534
Urokinase-type plasminogen activator (uPA) is one of the components of
blood's fibrinolytic cascade, uPA nets as a broad spectrum proteolyti
c enzyme involved in different physio-pathological processes including
cellular fibrinolysis, adhesion, migration, invasion and remodeling.
Here. we present evidence that uPA participates in myogenesis, a proce
ss which requires drastic cell membrane reorganization, leading to the
plurinucleated myotube from the progenitor myoblast. We have dissecte
d the expression of uPA throughout the different myogenic compartments
and found an increase in uPA enzymatic activity associated with myotu
be formation in C2C12 myoblast cells, with uPA mRNA increasing prior t
he onset of fusion and differentiation, When both fusion and different
iation were blocked by specific inhibitors (DMSO, cytochalasin B) the
levels of uPA were strongly downregulated. This process was reversible
and specific: the removal of the inhibitors immediately restored the
Levels of uPA mRNA while the specific inhibition of uPA enzymatic acti
vity by an anti-uPA antibody resulted in a 50% reduction of the extent
of fusion and in the abrogation of muscle-specific gene products, suc
h as alpha-actin and MyoD. Moreover, the conversion of fibroblasts to
muscle-like cells upon acquisition of MyoD resulted in a dramatic incr
ease of uPA mRNA. which was partially due to transcriptional activatio
n of the uPA gene. These results indicate that the increase in uPA exp
ression prior to fusion and differentiation occurs via a MyoD-mediated
mechanism whereas the normal MyoD expression requires the plasminogen
activation-dependent activity of this protease. Therefore. these stud
ies extend the sphere of influence of myogenic factors to fibrinolysis
. an intrinsic component of the hematological system. Taken together,
one mechanism used by the myoblast cell to become a differentiated myo
tube, involving the inductive extracellular proteolysis of urokinase,
is proposed.